Search

everythinglearnresearchcommunity

for

Search:↓

Androgen receptor activity blocks Wnt/β-catenin signaling, affecting hair growth and skin cell balance.

Male genital development is driven by androgen signaling and understanding it could help address congenital anomalies.

Androgens may block hair growth signals, targeting this could treat hair loss.

Androgen is important in controlling stem cell differentiation, reducing fat development, and increasing lean mass.

Androgen Deprivation Therapy for prostate cancer often reduces sexual function but intermittent therapy may be more tolerable.

Women with polycystic ovary syndrome tend to have a longer anogenital distance.

Testosterone therapy may slightly improve sexual function in postmenopausal women, but its long-term safety is unknown.

Testing for CAG repeat polymorphism in the androgen receptor gene is not currently recommended for managing hypogonadism.

Testosterone therapy can improve sexual desire and function in postmenopausal women but should be used cautiously and not based solely on testosterone levels.

Antiandrogens have important biological effects, but more research is needed to understand them fully and compare their effectiveness and side effects to other treatments.

Treatment during development affects hormone balance and sexual behavior in male rats.

Mutations in certain receptors can cause diseases and offer new treatment options.

People with hair loss may have different levels of certain hormones due to changes in hormone processing.

Male rats have androgen receptors in their liver, which are different from proteins that bind estrogen.

New androgen receptor modulators show promise for treating diseases like prostate cancer and muscle wasting.

A woman had both Graham Little-Piccardi-Lassueur syndrome, causing hair loss, and complete androgen insensitivity syndrome, making her genetically male but physically female. This suggests androgens don't affect the hair loss condition.

The androgen receptor is a promising target for breast cancer treatment, especially in triple-negative cases, but more research is needed for personalized therapies.

Acne is an important sign of androgen excess disorders in women.

Testosterone therapy helped 63% of androgen-deficient women grow scalp hair, but more research is needed.

Ganoderma lucidum may help treat prostate cancer by blocking male hormones and slowing cancer cell growth.

Certain changes to the B-ring of androgen receptor ligands can increase their effectiveness for potential treatments of muscle and bone conditions.

Testosterone therapy can help improve mood, sexual function, and bone health in women with low androgen levels, but more research is needed to establish safe and effective guidelines.

PGD2 increases androgen receptor activity in hair cells, which could be targeted to treat hair loss.

New treatments for prostate cancer are less toxic and show promise, but more research is needed to enhance their effectiveness and reduce side effects.

A compound made by Pfizer can potentially stimulate hair growth and reduce oil production, making it a good candidate for topical use.

Androgens and SARMs play a role in body mass, frailty, skin health, and hair growth, and are used in treating prostate cancer, acne, and hair loss, with potential for new uses and improved versions in the future.

Antiandrogen drugs can reduce PSA levels in women with excess hair, suggesting PSA is a sign of male hormone activity in women.

Young men with early hair loss have slightly worse blood sugar and fat levels, suggesting possible health risks and need for monitoring.

Polygonum multiflorum extract helps hair grow longer and fights the effects of hormones that cause hair loss.

The conclusion is that while oral contraceptive pills are effective for PCOS-related high androgen levels, new treatments with fewer side effects are needed.